Building momentum for malaria vaccine research and development: key considerations

To maintain momentum towards improved malaria control and elimination, a vaccine would be a key addition to the intervention toolkit. Two approaches are recommended: (1) promote the development and short to medium term deployment of first generation vaccine candidates and (2) support innovation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitnis, Chetan E., Schellenberg, David, Vekemans, Johan, Asturias, Edwin J., Bejon, Philip, Collins, Katharine A., Crabb, Brendan S., Herrera, Socrates, Laufer, Miriam, Rabinovich, N. Regina, Roestenberg, Meta, Shearley, Adelaide, Tinto, Halidou, Wentworth, Marian, O’Brien, Kate, Alonso, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682132/
https://www.ncbi.nlm.nih.gov/pubmed/33228666
http://dx.doi.org/10.1186/s12936-020-03491-3
_version_ 1783612648208728064
author Chitnis, Chetan E.
Schellenberg, David
Vekemans, Johan
Asturias, Edwin J.
Bejon, Philip
Collins, Katharine A.
Crabb, Brendan S.
Herrera, Socrates
Laufer, Miriam
Rabinovich, N. Regina
Roestenberg, Meta
Shearley, Adelaide
Tinto, Halidou
Wentworth, Marian
O’Brien, Kate
Alonso, Pedro
author_facet Chitnis, Chetan E.
Schellenberg, David
Vekemans, Johan
Asturias, Edwin J.
Bejon, Philip
Collins, Katharine A.
Crabb, Brendan S.
Herrera, Socrates
Laufer, Miriam
Rabinovich, N. Regina
Roestenberg, Meta
Shearley, Adelaide
Tinto, Halidou
Wentworth, Marian
O’Brien, Kate
Alonso, Pedro
author_sort Chitnis, Chetan E.
collection PubMed
description To maintain momentum towards improved malaria control and elimination, a vaccine would be a key addition to the intervention toolkit. Two approaches are recommended: (1) promote the development and short to medium term deployment of first generation vaccine candidates and (2) support innovation and discovery to identify and develop highly effective, long-lasting and affordable next generation malaria vaccines.
format Online
Article
Text
id pubmed-7682132
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76821322020-11-24 Building momentum for malaria vaccine research and development: key considerations Chitnis, Chetan E. Schellenberg, David Vekemans, Johan Asturias, Edwin J. Bejon, Philip Collins, Katharine A. Crabb, Brendan S. Herrera, Socrates Laufer, Miriam Rabinovich, N. Regina Roestenberg, Meta Shearley, Adelaide Tinto, Halidou Wentworth, Marian O’Brien, Kate Alonso, Pedro Malar J Commentary To maintain momentum towards improved malaria control and elimination, a vaccine would be a key addition to the intervention toolkit. Two approaches are recommended: (1) promote the development and short to medium term deployment of first generation vaccine candidates and (2) support innovation and discovery to identify and develop highly effective, long-lasting and affordable next generation malaria vaccines. BioMed Central 2020-11-23 /pmc/articles/PMC7682132/ /pubmed/33228666 http://dx.doi.org/10.1186/s12936-020-03491-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Chitnis, Chetan E.
Schellenberg, David
Vekemans, Johan
Asturias, Edwin J.
Bejon, Philip
Collins, Katharine A.
Crabb, Brendan S.
Herrera, Socrates
Laufer, Miriam
Rabinovich, N. Regina
Roestenberg, Meta
Shearley, Adelaide
Tinto, Halidou
Wentworth, Marian
O’Brien, Kate
Alonso, Pedro
Building momentum for malaria vaccine research and development: key considerations
title Building momentum for malaria vaccine research and development: key considerations
title_full Building momentum for malaria vaccine research and development: key considerations
title_fullStr Building momentum for malaria vaccine research and development: key considerations
title_full_unstemmed Building momentum for malaria vaccine research and development: key considerations
title_short Building momentum for malaria vaccine research and development: key considerations
title_sort building momentum for malaria vaccine research and development: key considerations
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682132/
https://www.ncbi.nlm.nih.gov/pubmed/33228666
http://dx.doi.org/10.1186/s12936-020-03491-3
work_keys_str_mv AT chitnischetane buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT schellenbergdavid buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT vekemansjohan buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT asturiasedwinj buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT bejonphilip buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT collinskatharinea buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT crabbbrendans buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT herrerasocrates buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT laufermiriam buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT rabinovichnregina buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT roestenbergmeta buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT shearleyadelaide buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT tintohalidou buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT wentworthmarian buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT obrienkate buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations
AT alonsopedro buildingmomentumformalariavaccineresearchanddevelopmentkeyconsiderations

Ejemplares similares